Abstract
Atherosclerosis has traditionally been attributed to disordered cholesterol metabolism with associated accumulation of lipid substrate in the arterial wall. It is now believed that systemic and local inflammatory events mediate all phases of plaque development, progression, and degeneration. No longer regarded as a bland, mechanical process, plaque evolution is now best understood as a pitched battle between proinflammatory and anti-inflammatory cellular and molecular elements. Not unlike models of chronic wound healing or ischemia-reperfusion, the biologic state of a plaque at any given time is transient and mutable, reflecting a dynamic balance of numerous local and circulating inflammatory forces. Dreaded complications of the disease such as myocardial infarction and stroke result from acute shifts in this balance in favor of plaque instability and vulnerability over stable states of chronic inflammation. The purpose of this article is (1) to review the inflammatory pathogenesis of atherosclerosis on a molecular basis, (2) describe several of the emerging inflammatory biomarkers currently being investigated with particular interest in their possible roles as direct mediators of vascular disease, and (3) identify several important implications for diagnosis and therapy.
Similar content being viewed by others
References
R Ross (1999) ArticleTitleAtherosclerosis — an inflammatory disease N Engl J Med 340 115–126 Occurrence Handle10.1056/NEJM199901143400207 Occurrence Handle1:STN:280:DyaK1M%2FptFSqtQ%3D%3D Occurrence Handle9887164
R Ross JA Glomset (1953) ArticleTitleAtherosclerosis and the arterial smooth muscle cell: proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis Science 180 1332–1339 Occurrence Handle10.1126/science.180.4093.1332
R Ross JA Glomset (1976) ArticleTitleThe pathogenesis of antherosclerosis N Engl J Med 295 369–377,420 Occurrence Handle819830 Occurrence Handle1:STN:280:DyaE283itVejtQ%3D%3D Occurrence Handle10.1056/NEJM197608122950707
InstitutionalAuthorNameEUROASPIRE (1997) ArticleTitlea European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results Eur Heart J 18 1569–1582
P Greenland MD Knoll J Stamler et al. (2003) ArticleTitleMajor risk factors as antecedents of fatal and nonfatal coronary heart disease events JAMA 290 891–897 Occurrence Handle10.1001/jama.290.7.891 Occurrence Handle12928465
RW Alexander (1994) ArticleTitleInflammation and coronary artery disease N Engl J Med 331 468–469 Occurrence Handle10.1056/NEJM199408183310709 Occurrence Handle8035844 Occurrence Handle1:STN:280:DyaK2czgvFKqtQ%3D%3D
HC Stary AB Chandler S Glagov et al. (1994) ArticleTitleA definition of intimal fatty streak, and intermediate lesions of atherosclerosis Circulation 89 2462–2478 Occurrence Handle8181179 Occurrence Handle1:STN:280:DyaK2c3js1yhsA%3D%3D
HC Stary AB Chandler RE Disnsmore et al. (1995) ArticleTitleA definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis Circulation 92 1355–1374 Occurrence Handle1:STN:280:DyaK2Mzns1OrsQ%3D%3D Occurrence Handle7648691
AN Sidawy (2000) Basic considerations of the arterial wall in health and disease In: Rutherford Vascular Surgery EditionNumber5 W. B. Saunders Philadelphia 60–72
R Ross (1995) ArticleTitleCell biology of atherosclerosis Annu Rev Physio 57 791–804 Occurrence Handle10.1146/annurev.ph.57.030195.004043 Occurrence Handle1:CAS:528:DyaK2MXksVeqsbY%3D
C Napoli FP D’Armiento FP Mancini et al. (1997) ArticleTitleFatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia: intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions J Clin Invest 100 2680–2690 Occurrence Handle9389731 Occurrence Handle10.1172/JCI119813 Occurrence Handle1:CAS:528:DyaK2sXotVaktLo%3D
A Faggiotto R Ross L Harker (1984) ArticleTitleStudies of hypercholesterolemia in the nonhuman primate: changes that lead to fatty streak formation Atherosclerosis 4 323–340 Occurrence Handle1:CAS:528:DyaL2cXlt1yht78%3D
HC Stary (1996) The histological classification of atherosclerotic lesions in human coronary arteries V Fuster R Ross EJ Topol (Eds) Atherosclerosis and Coronary Artery Disease, Vol. 1 Lippincott-Raven Philadelphia 463–474
Y Higashi S Sasaki K Nakagawa H Matsuura T Oshima K Chayama (2002) ArticleTitleEndothelial function and oxidative stress in renovascular hypertension N Engl J Med 346 1954–1962 Occurrence Handle10.1056/NEJMoa013591 Occurrence Handle1:CAS:528:DC%2BD38Xks1SqtLo%3D Occurrence Handle12075056
U Landmesser B Hornig H Drexler (2004) ArticleTitleEndothelial function: a critical determinant in atherosclerosis? Circulation 109 IssueID21 Suppl 1 II27–33 Occurrence Handle10.1161/01.CIR.0000129501.88485.1f Occurrence Handle15173060
MA Gonzales AP Selwyn (2003) ArticleTitleEndothelial function, inflammation, and prognosis in cardiovascular disease Am J Med 115 IssueIDSuppl 8A 99S–106S Occurrence Handle10.1016/j.amjmed.2003.09.016
TT Keller AT Mairuhu MD Kruif Particlede et al. (2003) ArticleTitleInfections and endothelial cells Cardiovasc Res 60 40–48 Occurrence Handle10.1016/S0008-6363(03)00354-7 Occurrence Handle14522405 Occurrence Handle1:CAS:528:DC%2BD3sXns12ktbw%3D
SR Steele MJ Martin PS Mullenix JV Crawford DS Cuadrado CA Andersen (2004) ArticleTitleCarotid artery stenosis following radiation therapy for head and neck cancer—should we be more aggressive in focused high-risk population screening? Am J Surg 187 594–598 Occurrence Handle15135672 Occurrence Handle10.1016/j.amjsurg.2004.01.014
Z Al Aly JC Edwards (2004) ArticleTitleVascular biology in uremia: insights into novel mechanisms of vascular injury Adv Chronic Kidney Dis 11 310–318 Occurrence Handle15241745 Occurrence Handle10.1053/j.arrt.2004.04.006
G Basta AM Schmidt R Caterina ParticleDe (2004) ArticleTitleAdvanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes Cardiovasc Res 63 582–592 Occurrence Handle10.1016/j.cardiores.2004.05.001 Occurrence Handle15306213 Occurrence Handle1:CAS:528:DC%2BD2cXmslertLc%3D
Y Asanuma A Oeser AK Shintani et al. (2003) ArticleTitlePremature coronary-artery atherosclerosis in systemic lupus erythematososus N Engl J Med 349 2407–2415 Occurrence Handle10.1056/NEJMoa035611 Occurrence Handle1:CAS:528:DC%2BD3sXpvFGqtbw%3D Occurrence Handle14681506
P Libby D Egan S Skarlatos (1997) ArticleTitleRoles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research Circulation 96 4095–4103 Occurrence Handle9403635 Occurrence Handle1:STN:280:DyaK1c%2FmsFyqsQ%3D%3D
MA Albert PM Ridker (2004) ArticleTitleInflammatory biomarkers in African Americans: a potential link to accelerated atherosclerosis Rev Cardiovasc Med 5 IssueIDSuppl 3 S22–27 Occurrence Handle15303082
L Jonasson J Holm O Skalli G Bondjers GK Hansson (1986) ArticleTitleRegional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque Arteriosclerosis 6 131–138 Occurrence Handle2937395 Occurrence Handle1:STN:280:DyaL287lvVCqsA%3D%3D
T Ito U Ikeda (2003) ArticleTitleInflammatory cytokines and cardiovascular disease Curr Drug Targets Inflamm Allergy 2 257–265 Occurrence Handle14561160 Occurrence Handle10.2174/1568010033484106 Occurrence Handle1:CAS:528:DC%2BD3sXmsFOhsL8%3D
A Strom A Franzen C Wangnerud et al. (2004) ArticleTitleAltered vascular remodeling in osteopontin-deficient atherosclerotic mice J Vasc Res 41 314–322 Occurrence Handle10.1159/000079205 Occurrence Handle15218333 Occurrence Handle1:CAS:528:DC%2BD2cXnvFamtbc%3D
M Yamaoka-Tojo T Tojo T Masuda et al. (2003) ArticleTitleC-reactive protein-induced production of interleuking-18 in human endothelial cells: a mechanism of orchestrating cytokine cascade in acute coronary syndrome Heart Vessels 18 183–187 Occurrence Handle10.1007/s00380-003-0719-7 Occurrence Handle14520485
JK Damas T Waehre A Yndestad et al. (2003) ArticleTitleInterleukin-7-mediated inflammation in unstable angina: possible role of chemokines and platelets Circulation 107 2670–2676 Occurrence Handle10.1161/01.CIR.0000070542.18001.87 Occurrence Handle12742982 Occurrence Handle1:CAS:528:DC%2BD3sXjvFKjur8%3D
MF Linton S Fazio (2003) ArticleTitleMacrophages, inflammation, and atherosclerosis Int J Obes Relat Metab Disord 21 IssueIDsuppl 3 S35–40 Occurrence Handle10.1038/sj.ijo.0802498 Occurrence Handle1:CAS:528:DC%2BD2cXls1Gk
M Jeziorska C McCollum DE Wooley (1997) ArticleTitleMast cell distribution, activation, and phenotype in atherosclerotic lesions of human carotid arteries J Pathol 183 248
S Bhakdi M Torzewski M Klouche M Hemmes (1999) ArticleTitleComplement and atherogenesis: binding of CRP to degraded nonoxidized LDL enhances complement activation Arterioscler Thromb Vasc Biol 19 2348–2354 Occurrence Handle10521363 Occurrence Handle1:CAS:528:DyaK1MXmvFGit70%3D
MJ Leskinen PT Kovanen KA Lindstedt (2003) ArticleTitleRegulation of smooth muscle cell growth, function and death by activated mast cells—a potential mechanism for the weakening and rupture of atherosclerotic plaques Biochem Pharmaeol 66 1493–1498 Occurrence Handle10.1016/S0006-2952(03)00503-3 Occurrence Handle1:CAS:528:DC%2BD3sXnvVeqsrc%3D
Y Sheikine GK Hansson (2004) ArticleTitleChemokines and atherosclerosis Ann Med 36 98–118 Occurrence Handle10.1080/07853890310019961 Occurrence Handle15119830 Occurrence Handle1:CAS:528:DC%2BD2cXjtFCns7k%3D
Caterina ParticleDe A Zampoli (2004) ArticleTitleFrom asthma to atherosclerosis—5-lipoxygenase, leukotrienes, and inflammation N Engl J Med 350 4–7 Occurrence Handle10.1056/NEJMp038190 Occurrence Handle14702420
JL Cracowski (2004) ArticleTitleIsoprostanes: an emerging role in vascular physiology and disease? Chem Phys Lipids 128 75–83 Occurrence Handle10.1016/j.chemphyslip.2003.10.006 Occurrence Handle15037154 Occurrence Handle1:CAS:528:DC%2BD2cXpsVyjtQ%3D%3D
T Bombeli BR Schwartz JM Harlan (1998) ArticleTitleAdhesion of activated platelets to endothelial cells: evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-l), ab integrin, and GPIba J Exp Med 187 329–339 Occurrence Handle10.1084/jem.187.3.329 Occurrence Handle9449713 Occurrence Handle1:CAS:528:DyaK1cXnslOrsQ%3D%3D
A Hamsten B Wiman U Faire Particlede M Blomback (1985) ArticleTitleIncreased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction N Engl J Med 313 1557–1563 Occurrence Handle3934538 Occurrence Handle1:STN:280:DyaL28%2FmsFegtw%3D%3D Occurrence Handle10.1056/NEJM198512193132501
K Mawatari S Kakui N Harada et al. (2004) ArticleTitleEndothelin-1(1-31) levels are increased in atherosclerotic lesions of the thoracic aorta of hypercholesterolemic hamsters Atherosclerosis 175 203–212 Occurrence Handle10.1016/j.atherosclerosis.2003.10.015 Occurrence Handle15262175 Occurrence Handle1:CAS:528:DC%2BD2cXlsl2gtrg%3D
E Flak (1996) Pathogenesis of plaque disruption V Fuster R Ross EJ Topol (Eds) Atherosclerosis and coronary artery disease, Vol. 2 Lippincott-Raven Philadelphia 492–510
PM Ridker CH Hennekens N Rifai (2001) ArticleTitleNovel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral vascular disease JAMA 285 2481–2485 Occurrence Handle10.1001/jama.285.19.2481 Occurrence Handle11368701 Occurrence Handle1:CAS:528:DC%2BD3MXkt1CnsLc%3D
G Liuzzo LM Biasucci JR Gallimore et al. (1994) ArticleTitleThe prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina N Engl J Med 331 417–424 Occurrence Handle10.1056/NEJM199408183310701 Occurrence Handle1:STN:280:DyaK2czgvFKruw%3D%3D Occurrence Handle7880233
HP Kohler PJ Grant (2000) ArticleTitlePlasminogen-activator inhibitor type 1 and coronary artery disease N Engl J Med 342 1792–1801 Occurrence Handle10.1056/NEJM200006153422406 Occurrence Handle10853003 Occurrence Handle1:CAS:528:DC%2BD3cXksVequ7Y%3D
M Hoylaerts DC Rijken HR Lijnen D Collén (1982) ArticleTitleKinetics of the activation of plasminogen by human tissue plasminogen activator: role of fibrin J Biol Chem 257 2912–2919 Occurrence Handle7199524 Occurrence Handle1:CAS:528:DyaL38Xhslylur8%3D
J Schneiderman MS Sawdey MR Keeton et al. (1992) ArticleTitleIncreased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries Proc Natl Acad Sci USA 89 6998–7002 Occurrence Handle1495992 Occurrence Handle10.1073/pnas.89.15.6998 Occurrence Handle1:CAS:528:DyaK38XlsVygtbw%3D
I Juhan-Vague SDM Pyke MC Alessi J Jespersen F Haverkate SG Thompson (1996) ArticleTitleFibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris Circulation 94 2057–2063 Occurrence Handle8901651 Occurrence Handle1:STN:280:DyaK2s%2FlsleisA%3D%3D
C Held P Hjemdahl N Rehnqvist et al. (1997) ArticleTitleFibrinolytic variables and cardiovascular prognosis in patients with stable angina pectoris treated with verapamil or metroprolol: results from the Angina Prognosis Study in Stockholm Circulation 95 2380–2386 Occurrence Handle9170400 Occurrence Handle1:CAS:528:DyaK2sXjslKhsLk%3D
I Juhan-Vague C Roul MC Alessi JP Ardissone M Heim P Vague (1989) ArticleTitleIncreased plasminogen activator inhibitor activity in non-insulin-dependent diabetic patient—relationship with plasma insulin Thromb Haemost 61 370–373 Occurrence Handle2678583 Occurrence Handle1:STN:280:DyaK3c%2FitVWntA%3D%3D
CA Labarrere D Pitts DR Nelson WP Faulk (1995) ArticleTitleVascular tissue plasminogen activator and the development of coronary artery disease in heart-transplant recipients N Engl J Med 333 1111–1116 Occurrence Handle10.1056/NEJM199510263331704 Occurrence Handle7565949 Occurrence Handle1:STN:280:DyaK28%2FhtlGjtw%3D%3D
SP Mazer LE Rabbani (2004) ArticleTitleEvidence for C-reactive protein’s (CRP) role in vascular disease: atherothrombosis, immuno-regulation and CRP J Thromb Thrombolysis 17 95–105 Occurrence Handle10.1023/B:THRO.0000037664.77460.d8 Occurrence Handle15306744 Occurrence Handle1:CAS:528:DC%2BD2cXmsVKksbw%3D
J Torzewski M Torzewski DE Bowyer et al. (1998) ArticleTitleC-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries Arterioscler Thromb Vasc Biol 28 1386–1392
RD Dannenberg AJ Szalai RV Swaminathan et al. (2003) ArticleTitleIncreased thrombogenesis after arterial injury in human C-reactive protein-transgenic mice Circulation 5;108 512–515 Occurrence Handle10.1161/01.CIR.0000085568.13915.1E Occurrence Handle1:CAS:528:DC%2BD3sXlvVWqsbk%3D
M Torzewski C Rist RF Mortensen et al. (2000) ArticleTitleC-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis Arterioscler Thromb Vasc Biol 20 2094–2099 Occurrence Handle10978254 Occurrence Handle1:CAS:528:DC%2BD3cXntV2it7c%3D
MK Chang CJ Binder M Torzewski JL Witztum (2002) ArticleTitleC-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: phosphorylcholine of oxidized phospholipids Proc Natl Acad Sci USA 99 125115–125117
T Fu J Borensztajn (2002) ArticleTitleMacrophage uptake of LDL bound to aggregated C-reactive protein: possible mechanism of foam-cell formation in atherosclerotic lesions Biochem J 266 IssueIDPt 1 195–201
MA Zimmerman CH Selzman C Cothren et al. (2003) ArticleTitleDiagnostic implications of C-reactive protein Arch Surg 138 220–224 Occurrence Handle10.1001/archsurg.138.2.220 Occurrence Handle12578424
TJ Wang BH Nam PW Wilson et al. (2002) ArticleTitleAssociation of C-reactive protein and carotid atherosclerosis in men and women: the Framingham Heart Study Atherioscler Thromb Vasc Biol 22 1412–1413
PM Ridker M Cushman MJ Stampfer RP Tracy CR Hennekens (1998) ArticleTitlePlasma concentration of C-reactive protein and risk of developing peripheral vascular disease Circulation 97 425–428 Occurrence Handle1:STN:280:DyaK1c7ktVKktQ%3D%3D Occurrence Handle9490235
BC Berk WS Weintraub RW Alexander (1990) ArticleTitleElevation of C-reactive protein in “active” coronary artery disease Am J Cardiol 65 168–172 Occurrence Handle10.1016/0002-9149(90)90079-G Occurrence Handle2296885 Occurrence Handle1:STN:280:DyaK3c7hvFCmsg%3D%3D
H Toss B Lindahl A Siegbahn et al. (1887) ArticleTitlePrognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease Circulation 96 4204–4210
F Haverkate SG Thompson SD Pyke et al. (1997) ArticleTitleProduction of C-reactive protein and risk of coronary events in stable and unstable angina Lancet 349 462–466 Occurrence Handle10.1016/S0140-6736(96)07591-5 Occurrence Handle9040576 Occurrence Handle1:STN:280:DyaK2s7pt12rtg%3D%3D
K Pietila A Harmoninen W Hermens et al. (1993) ArticleTitleSerum C-reactive protein and infarct size in myocardial infarct patients with a closed versus and open infarct-related coronary artery after thrombolytic therapy Eur Heart J 14 915–919 Occurrence Handle8375415 Occurrence Handle1:STN:280:DyaK3szoslegtg%3D%3D
CA Labarrere JB Lee DR Nelson et al. (2002) ArticleTitleC-reactive protein, arterial endothelial activation, and development of transplant coronary artery disease: a prospective study Lancet 30 IssueID9344 1436–1437
Mullenix PS, Steele SR, Martin MJ, Starnes BW, Andersen CA. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of carotid stenosis. J Am Coll Surg 2004;194(3S)
Mullenix PS, Steele SR, Martin MJ, Starnes BW, Andersen CA. C-reactive protein and traditional vascular risk factors in the prediction of carotid stenosis. Presented at the 19th Annual Meeting of the Western Vascular Society, Victoria, BC, September 2004
B Alvarez Garcia C Ruiz P Chacon JA Sabin M Matas (2003) ArticleTitleHigh-sensitivity C-reactive protein in high-grade carotid stenosis: risk marker for unstable carotid plaque J Vasc Surg 38 1018–1024 Occurrence Handle10.1016/S0741-5214(03)00709-2 Occurrence Handle14603210
D Milazzo LM Biasucci N Luciani et al. (1999) ArticleTitleElevated levels of C-reactive protein before coronary artery bypass grafting predict recurrence of ischemic events Am J Cardial 84 459–461 Occurrence Handle10.1016/S0002-9149(99)00333-1 Occurrence Handle1:STN:280:DyaK1Mzps1WlsQ%3D%3D
A Buffon G Liuzzo LM Biasucci et al. (1999) ArticleTitlePreprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty J Am Call Cardial 34 1512–1521 Occurrence Handle10.1016/S0735-1097(99)00348-4 Occurrence Handle1:STN:280:DC%2BD3c%2FhslylsQ%3D%3D
DP Chew DL Bhatt MA Robbins et al. (2001) ArticleTitleIncremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention Circulation 104 992–997 Occurrence Handle11524391 Occurrence Handle10.1161/hc3401.095074 Occurrence Handle1:CAS:528:DC%2BD3MXntlKisrY%3D
PM Ridker NJ Brown DE Vaughan et al. (2004) ArticleTitleEstablished and emerging plasma biomarkers in the prediction of first atherothrombotic events Circulation 109 IssueIDSuppl IV IV-6–IV19 Occurrence Handle10.1161/01.CIR.0000133444.17867.56
TA Pearson GA Mensah RW Alexander et al. (2003) ArticleTitleMarkers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association Circulation 107 499–511 Occurrence Handle10.1161/01.CIR.0000052939.59093.45 Occurrence Handle12551878
LE Spieker F Ruschitzka TF Luscher G Noll (2004) ArticleTitleHDL and inflammation and atherosclerosis Curr Drug Targets Immune Endocr Metabol Disord 4 51–57 Occurrence Handle15032626 Occurrence Handle10.2174/1568008043340044 Occurrence Handle1:CAS:528:DC%2BD2cXisVaitr0%3D
S Pennathur C Bergt B Shao et al. (2004) ArticleTitleHuman atherosclerotic intima and blood of patients with established coronary artery disease contain high density lipoprotein damaged by reactive nitrogen species J Biol Chem 279 42977–42983 Occurrence Handle10.1074/jbc.M406762200 Occurrence Handle15292228 Occurrence Handle1:CAS:528:DC%2BD2cXotVOgt7Y%3D
P Dandona A Aljada S Dhindsa R Garg (2003) ArticleTitleInsulin as an anti-inflammatory and antiatherosclerotic hormone Clin Cornerstone Suppl 4 S13–20 Occurrence Handle10.1016/S1098-3597(03)90062-7 Occurrence Handle14986904
R Spanbroek AJ Habenicht (2003) ArticleTitleThe potential role of antileukotriene drugs in atherosclerosis Drug News Perspect 16 485–409 Occurrence Handle14668944 Occurrence Handle10.1358/dnp.2003.16.8.829345 Occurrence Handle1:CAS:528:DC%2BD2cXhvFKqsQ%3D%3D
D Vishnevetsky VA Kiyanista PJ Gandhi (2004) ArticleTitleCD40 ligand: a novel target in the fight against cardiovascular disease Ann Pharmacother 38 1500–1508 Occurrence Handle10.1345/aph.1D611 Occurrence Handle15280513 Occurrence Handle1:CAS:528:DC%2BD2cXnslyitrw%3D
P Puddu GM Puddu A Muscari (2003) ArticleTitlePeroxisome proliferators-activated receptors: are they involved in atherosclerosis progression? Int J Cardiol 90 133–140 Occurrence Handle10.1016/S0167-5273(02)00565-X Occurrence Handle12957742
Goings K, Steele SR, Martin MJ, Mullenix PS, Andersen CA. The inflammatory component of carotid stenosis: a case report. Presented at the 31st Annual Meeting of the Society for Military Vascular Surgery, Washington, DC, November 2003
E Niederberger C Manderscheid S Grosch et al. (2004) ArticleTitleEffects of the selective COX-2 inhibitors celecoxib and rofecoxib on human vascular cells Biochem Pharmacol 15 341–350 Occurrence Handle10.1016/j.bcp.2004.03.029 Occurrence Handle1:CAS:528:DC%2BD2cXkvV2hsL4%3D
YB Tripathi MM Reddy RS Pandey et al. (2004) ArticleTitleAnti-inflammatory properties of BHUx, a polyherbal fomulation to prevent atherosclerosis Inflammopharmacology 12 131–152 Occurrence Handle10.1163/1568560041352301 Occurrence Handle15265316 Occurrence Handle1:CAS:528:DC%2BD2cXntVyhs7w%3D
D Schonbeck P Libby (2004) ArticleTitleInflammation, immunity and HMG-CoA reductase inhibitors: statins as antiinflammatory agents? Circulation 109 IssueID21 Supp 1 II18–26 Occurrence Handle10.1161/01.CIR.0000129505.34151.23 Occurrence Handle15173059 Occurrence Handle1:CAS:528:DC%2BD2cXkt1arsL8%3D
C Viedt W Shen J Fei et al. (2003) ArticleTitleHMG-CoA reductase inhibition reduces the proinflammatory activation of human vascular smooth muscle cells by the terminal complement factor C5b-9 Basic Res Cardiol 98 353–361 Occurrence Handle14556080 Occurrence Handle1:CAS:528:DC%2BD3sXpsl2qtrw%3D
MH Shishehbor RJ Aviles ML Brennan et al. (2003) ArticleTitleAssociation of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy JAMA 289 1675–1680 Occurrence Handle10.1001/jama.289.13.1675 Occurrence Handle1:CAS:528:DC%2BD3sXisF2is7s%3D Occurrence Handle12672736
JL Martin-Ventura M Ortego P Esbrit et al. (2003) ArticleTitlePossible role of parathyroid hormone-related protein as a proinflammatory cytokine in atherosclerosis Stroke 34 1783–1789 Occurrence Handle10.1161/01.STR.0000078371.00577.76 Occurrence Handle12805493 Occurrence Handle1:CAS:528:DC%2BD3sXkvFyjurw%3D
AS Greenberg (2003) ArticleTitleThe expanding scope of the metabolic syndrome and implications for the management of cardiovascular risk in type 2 diabetes with particular focus on the emerging role of the thiazolidinediones J Diabetes Complications 17 218–228 Occurrence Handle10.1016/S1056-8727(03)00002-3 Occurrence Handle12810246
B Schieffer C Bunte J Witte et al. (2004) ArticleTitleComparative effects of AT1-antagonism and angiotensin-converting enzyme inhibition on markers of inflammation and platelet aggregation in patients with coronary artery disease J Am Coll Cardiol 44 362–368 Occurrence Handle10.1016/j.jacc.2004.03.065 Occurrence Handle15261932 Occurrence Handle1:CAS:528:DC%2BD2cXlslyhsbw%3D
MJ Sharman JS Volek (2004) ArticleTitleWeight loss leads to reductions in inflammatory biomarkers after a very low-carbohydrate and low-fat diet in overweight men Clin Sci (Land) 107 365–369 Occurrence Handle10.1042/CS20040111 Occurrence Handle1:CAS:528:DC%2BD2cXnslOqu7o%3D
M Troseid KT Lappegard JK Damas et al. (2004) ArticleTitleExercise reduces plasma levels of the chemokines MCP-1 and IL-8 in subjects with the metabolic syndrome Eur Heart J 25 349–355 Occurrence Handle10.1016/j.ehj.2003.12.006 Occurrence Handle14984925 Occurrence Handle1:CAS:528:DC%2BD2cXhsV2gsrs%3D
S Carr A Farb WH Pearce R Virmani JS Vao (1996) ArticleTitleAtherosclerotic plaque rupture in symptomatic carotid artery stenosis J Vasc Surg 23 755–765 Occurrence Handle8667496 Occurrence Handle10.1016/S0741-5214(96)70237-9 Occurrence Handle1:STN:280:DyaK283isFCjtg%3D%3D
T Rundek MS Elkind J Pittman et al. (2002) ArticleTitleCarotid intima-media thickness is associated with allelic variants of stromelysin-1, IL-6, and hepatic lipase genes: the Northern Manhattan Prospective Cohort Study Stroke 33 1420–1423 Occurrence Handle10.1161/01.STR.0000015558.63492.B6 Occurrence Handle11988625
WE Shaalan H Cheng B Gerwertz et al. (2004) ArticleTitleDegree of carotid plaque calcification in relation to symptomatic outcome and plaque inflammation J Vase Surg 40 262–269 Occurrence Handle10.1016/j.jvs.2004.04.025
Bicknell CD, Foale R, Mudra H, Cheshire NJ. Biological and duplex features of carotid plaques predict embolization during carotid endoluminal intervention. Presented at the International Congress XVII on Endovascular Interventions, Phoenix, AZ, February 8-12, 2004
Fujitani RM, Gelfand D, Gordon IL, et al. Correlation between CTA-acquired images of carotid artery plaque morphology with clinical neurologic symptomatology. Presented at the 20th Annual Meeting of the Western Vascular Society, Victoria, BC, September 2004
Lang W, Balzer KM, Muller KM, Fellner FA. Risk evaluation of carotid plaque morphology by ultrasonographic gray scale analysis and angioscopy: can we detect high-risk plaques for carotid angioplasty? Presented at the International Congress XVII on Endovascular Interventions, Phoenix, AZ, February 8-12, 2004
M Shapiro S Hanon D Misra (2004) ArticleTitleDrug-eluting stents Hosp Phys 12 11–20
PW Serruys F Unger BA Hout Particlevan et al. (1999) ArticleTitleThe ARTS study (Arterial Revascularization Therapies Study) Semin Interv Cardiol 4 209–219 Occurrence Handle10738354 Occurrence Handle1:STN:280:DC%2BD3c3gsVChsw%3D%3D
SO Marx AR Marks (2001) ArticleTitleBench to bedside: the development of rapamycin and its application to stent restenosis [editorial] Circulation 104 852–855 Occurrence Handle11514367 Occurrence Handle1:CAS:528:DC%2BD3MXmvFKmsrk%3D
MC Morice PW Serruys JE Sousa et al. (2002) ArticleTitleA randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization N Engl J Med 346 1773–1780 Occurrence Handle10.1056/NEJMoa012843 Occurrence Handle1:CAS:528:DC%2BD38Xkt1Olsbw%3D Occurrence Handle12050336
PW Serruys M Degertekin K Tanabe et al. (2002) ArticleTitleIntravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (Randomized study with the sirolimus-eluting Velocty balloon-expandable stents in the treatment of patients with de novo native coronary artery Lesions) trial Circulation 106 798–803 Occurrence Handle12176950 Occurrence Handle10.1161/01.CIR.0000025585.63486.59 Occurrence Handle1:CAS:528:DC%2BD38XntVertb4%3D
Author information
Authors and Affiliations
Corresponding author
Additional information
This is an original work by the above authors. The opinions expressed in this article do not necessarily reflect those of the United States (US) Government, the US Department of Defense, or Madigan Army Medical Center.
About this article
Cite this article
Mullenix, P.S., Andersen, C.A. & Starnes, B.W. Atherosclerosis as Inflammation. Ann Vasc Surg 19, 130–138 (2005). https://doi.org/10.1007/s10016-004-0153-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10016-004-0153-z